Home / Conferences and Events / Miami Thyroid Oncology Symposium

The 6th Annual Miami Thyroid Oncology Symposium will be held on October 27th and 28th, 2023

The 6th Annual Miami Thyroid Oncology Symposium will take place on October 27th and 28th, 2023. MTOS 2023 offers a platform for in-depth discussions of the science of thyroid cancer diagnosis and treatment in the era of precision medicine and molecular theranostics. In this unique scientific forum, practicing physicians learn how to adopt and incorporate new diagnostic and treatment tools and techniques into their daily practice. Contact MTOSContact@gmail.com with any questions.

About the Symposium

We welcome you to the 6th Miami Thyroid Oncology Symposium to discuss the rapidly expanding science of "Thyroid Oncology". A broad catalog of genomic and epigenomic markers has been identified and integrated into the cytologic and pathologic evaluation of nodular thyroid disease and thyroid cancer. Risk stratification systems that are critical for initial surgical treatment and subsequent use of radioactive iodine treatment rely more on distinct molecular markers involving theranostic considerations. The traditional characterization of tumor differentiation/de-differentiation for the purposes of clinical prognostic assessments and more importantly definition/redefinition of the role of RAI treatment for individual cancer phenotypes are now being expressed by molecular characteristics.

The symposium is a two-day program. The first day of the symposium on Friday, October 27th, 2023, where we will highlight Frontiers in Thyroid Oncology. This session brings together world-renowned experts presenting and discussing the state of the art in thyroid cancer diagnosis and treatment. The second day of the symposium on Saturday, October 28th, 2023, will feature a workshop on Advances in Radioactive Iodine (RAI) Theranostics, which will provide an in-depth overview of RAI theranostics and address current controversies on RAI imaging, ablation, and approaches for RAI-indifferent cancers.

The 2023 Miami Thyroid Oncology Symposium (MTOS) will be held in a hybrid format. The core faculty will gather at the MTOS conference center and jointly run sessions with the participation of international guest faculty and symposium registrants. The sessions will involve brief formal presentations, case discussions, panel debates, and Q&A. Technical topics will include video presentations as well.

We are committed to upholding the high-quality symposium standards we have built in the prior years. We are indebted to our world-renowned faculty for taking part in this exciting new scientific platform. We also hope to expand our attendance by reaching a larger national and international audience through the hybrid format.

Dade County Medical Association (DCMA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DCMA designates this educational activity for a maximum 0f 16 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Please note that CME’s will be awarded from DCMA